Last checked at 16 Nov 2009 13:39
16 November 2009
For immediate release
Proteome Sciences plc
("Proteome" or the "Company")
Holding(s) in Company
| TR-1: Notifications of Major Interests in Shares |
| 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: | Proteome Sciences plc | ||
| 2. Reason for notification (yes/no) | |||
| An acquisition or disposal of voting rights | Yes | ||
| An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | No | ||
| An event changing the breakdown of voting rights | No | ||
| Other (please specify):______________ | No | ||
| 3. Full name of person(s) subject to notification obligation: | Sanofi-Aventis Deutschland GmbH | ||
| 4. Full name of shareholder(s) (if different from 3): | |||
| 5. Date of transaction (and date on which the threshold is crossed or reached if different): | 23th October 2009 | ||
| 6. Date on which issuer notified: | 13th November 2009 | ||
| 7. Threshold(s) that is/are crossed or reached: | 7% | ||
| 8: Notified Details | |||||||
| A: Voting rights attached to shares | |||||||
| Class/type of shares If possible use ISIN code GB0003104196 | Situation previous to the triggering transaction | Resulting situation after the triggering transaction | |||||
| Number of shares 9,455,024 | Number of voting rights 9,455,024 | Number of shares 8,354,579 | Number of voting rights | Percentage of voting rights | |||
| Direct 8,354,579 | Indirect | Direct 6.29% | Indirect | ||||
| B: Financial Instruments | ||||
| Resulting situation after the triggering transaction | ||||
| Type of financial instrument | Expiration date | Exercise/ conversion period/date | No. of voting rights that may be acquired (if the instrument exercised/converted) | Percentage of voting rights |
| N/A | N/A | N/A | N/A | N/A |
| Total (A+B+C) | |
| Number of voting rights | Percentage of voting rights |
| 8,354,579 | 6.29% |
| 9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable: |
| Proxy Voting: | |
| 10. Name of proxy holder: | |
| 11. Number of voting rights proxy holder will cease to hold: | |
| 12. Date on which proxy holder will cease to hold voting rights: | |
| 13. Additional information: | |
| 14. Contact name: | Juergen Blieke or Reiner May |
| 15. Contact telephone name | 0049 69 305 4703 or 0049 69 305 80202 |
| 16. Contact address | |